| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701936 | Journal of Thoracic Oncology | 2017 | 9 Pages |
Abstract
In the current analysis, complete response from lung metastasis at 6 months after stereotactic body radiation therapy was significantly associated with both the maximum and mean values of pre-SABR 18FDG-PET/CT SUV. Longer-term trials are strongly advocated to improve the personalization of the monitoring of tumor response in patients with lung oligometastases and, consequently, monitoring of the cost-effectiveness of the health care.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Rosario MD, Alba MD, Gioacchino MSc, Niccolò MD, Francesco MD, Sergio MD, Umberto MD, Stefano MS, Ruggero MS, Matteo MD, Filippo MD,